# γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors

> **NCT06404281** · PHASE1 · RECRUITING · sponsor: **Changzhou No.2 People's Hospital** · enrollment: 9 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **BIOLOGICAL:** γδ T-PD-1 Ab cells

## Key facts

- **NCT ID:** NCT06404281
- **Lead sponsor:** Changzhou No.2 People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2024-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06404281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06404281, "γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06404281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*